Does Novo Nordisk’s slimmed down rebrand signal a new era of DTC revivalism?

Novo Nordisk, the Dandish drugmaker behind the weight-loss drugs Ozempic and Wegovy, announced it’s rebranding to “Novo” beginning this week. It’s part of a larger trend in healthcare branding .

Related

Amsterdam’s Brandt gallery celebrates 10th anniversary with major rebrand Creative Review

Baby Teeth rebrands Royal Society of Arts with archival system and Dame Judi Dench film Design Week

Studio Blackburn’s new identity for folding bike icon Brompton cements the brand’s place in British engineering heritage BP&O

An Apple alum revamped GM’s truck interface for the screen fatigue era Fast Company Design

Marina Willer crafts letters with light and projection for BFI London Film Festival’s new identity and campaign It's Nice That

What this elegant redesign of a sparkling water brand teaches us about packaging in 2026 Creative Boom

More from Fast Company Design on Hakken.